Diadema Partners’s Ventyx Biosciences VTYX Stock Holding History

Diadema Partners’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-200,000	Closed	-$1.81M	–	211
2025 Q4	$1.81M	Buy	200,000 +128,796	+181%	+$963K	0.31%	70
2025 Q3	$221K	Buy	+71,204	New	+$189K	0.06%	115

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Diadema Partners's VTYX Position: Q1 2026 in Review

Diadema Partners sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 200,000 shares — an estimated $1.81M sold.

Diadema Partners first reported a position in VTYX in Q3 2025 and held it in 2 quarters. The position peaked at $1.81M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Diadema Partners reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Diadema Partners sold 200,000 Ventyx Biosciences shares in Q1 2026, an estimated $1.81M.
Diadema Partners first reported a position in Ventyx Biosciences in Q3 2025 and held it in 2 quarters.
Diadema Partners's Ventyx Biosciences position peaked at $1.81M in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Diadema Partners's 13F filing for Q1 2026, filed 15 May 2026.